Genetic and clinical factors relating to warfarin dosing Jonas DE et al. - Recent studies have reported that polymorphisms in CYP4F2 might account for between 2 and 7% of the variation. Several prospective studies have evaluated genotype-guided dosing, but these have found negative results or were poorly designed. [more...]
